Am J Gastroenterol

1. HUANG SC, Su TH, Tseng TC, Liao SH, et al
   Pre-existing and new-onset metabolic dysfunctions increase cirrhosis and its complication risks in chronic hepatitis B.
   Am J Gastroenterol. 2024 Jun 26. doi: 10.14309/ajg.0000000000002915.
   

   >> Share

   
   
2. BERAN A, Mohamed MFH, Vargas A, Aboursheid T, et al
   Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients with Cirrhosis and Ascites: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002906.
   

   >> Share

   
   
3. ELHENCE H, Dodge JL, Kahn JA, Lee BP, et al
   Characteristics and Outcomes Among U.S. Commercially Insured Transgender Adults with Cirrhosis: A National Cohort Study.
   Am J Gastroenterol. 2024 Jun 25. doi: 10.14309/ajg.0000000000002907.
   

   >> Share

   
   
4. PARVATANENI S, Sarkis Y, Haugh M, Baker B, et al
   A comprehensive evaluation of emergency department utilization by patients with cirrhosis.
   Am J Gastroenterol. 2024 Jun 24. doi: 10.14309/ajg.0000000000002905.
   

   >> Share

   
   

   
   Anticancer Res

5. KOMATSU S, Yano Y, Mimura T, Minami A, et al
   Current Status of Conversion Hepatectomy After Sorafenib and Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.
   Anticancer Res. 2024;44:3097-3103.
   

   >> Share

   
   
6. MIZUNO F, Imai N, Mizuno K, Yokoyama S, et al
   Clinical Outcomes of Use of the Porous Glass Membrane Pumping Emulsification Device During Transarterial Chemoembolization for Hepatocellular Carcinoma.
   Anticancer Res. 2024;44:3185-3191.
   

   >> Share

   
   

   
   BMC Cancer

7. KANNO H, Hashimoto K, Sakai H, Ogata T, et al
   Safety and feasibility of liver resection including major hepatectomy for geriatric patients with hepatocellular carcinoma: a retrospective observational study.
   BMC Cancer. 2024;24:765.
   

   >> Share

   
   
8. YE JZ, Lu HZ, Zeng C, Lei G, et al
   A novel surgical scheme for hepatectomy in hepatocellular carcinoma patients with clinically significant portal hypertension.
   BMC Cancer. 2024;24:764.
   

   >> Share

   
   

   
   BMC Gastroenterol

9. AKBARIRAD M, Pezeshki Rad M, Nobakht H, Moodi Ghalibaf A, et al
   Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study.
   BMC Gastroenterol. 2024;24:212.
   

   >> Share

   
   
10. FANG S, Zhou Y
    Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma.
    BMC Gastroenterol. 2024;24:210.
    

    >> Share

    
    

    
    Dig Dis Sci

11. BROWN C, Hernandez R, Ford T, Aksan N, et al
    Inadequate Dietary Education and Poor Adherence to a High Protein, Low Sodium Diet in Cirrhosis: Mixed Methods Approach.
    Dig Dis Sci. 2024 Jun 28. doi: 10.1007/s10620-024-08526.
    

    >> Share

    
    

    
    Endoscopy

12. NIIYA F, Tamai N, Noda J, Azami T, et al
    A novel long-balloon dilator for endoscopic ultrasound-guided hepaticogastrostomy and bridging stenting with partial stent-in-stent method.
    Endoscopy. 2024;56.
    

    >> Share

    
    

    
    Eur Radiol

13. ZOU X, Liu L, Tan F, Tang H, et al
    Non-contrast-enhanced MR angiography of left gastric vein in patients with gastroesophageal varices: morphology and blood supply analysis.
    Eur Radiol. 2024;34:4686-4696.
    

    >> Share

    
    
14. PEREIRA PL, Siemou P, Rempp HJ, Hoffmann R, et al
    CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Eur Radiol. 2024;34:4663-4671.
    

    >> Share

    
    

    
    Gastroenterology

15. VAN KLEEF LA, Francque SM, Prieto-Ortiz JE, Sonneveld MJ, et al
    Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
    Gastroenterology. 2024;167:357-367.
    

    >> Share

    
    
16. NAIMIMOHASSES S, Bhat M
    Novel Multimodal Database for Metabolic Dysfunction-Associated Steatotic Liver Disease-Linking Genes to Outcomes.
    Gastroenterology. 2024;167:410-411.
    

    >> Share

    
    
17. SUI B, Wang R, Chen C, Kou X, et al
    Apoptotic Vesicular Metabolism Contributes to Organelle Assembly and Safeguards Liver Homeostasis and Regeneration.
    Gastroenterology. 2024;167:343-356.
    

    >> Share

    
    
18. KO S, Monga SP
    The dark side of human hepatocyte plasticity.
    Gastroenterology. 2024 Jun 25:S0016-5085(24)05116.
    

    >> Share

    
    
19. VENKATESWARAN N
    Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis.
    Gastroenterology. 2024 Jun 20:S0016-5085(24)05064.
    

    >> Share

    
    
20. ZHU CP, Liu SQ, Wang KQ, Xiong HL, et al
    Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension.
    Gastroenterology. 2024 Jun 19:S0016-5085(24)05062.
    

    >> Share

    
    

    
    Hepatology

21. KANG K, Wu Y
    Letter to the Editor: Regarding the use of decision curve analysis in predicting long-term complications of liver cirrhosis.
    Hepatology. 2024 Jun 21. doi: 10.1097/HEP.0000000000000945.
    

    >> Share

    
    
22. RATZIU V, Yilmaz Y, Lazas D, Friedman SL, et al
    Aramchol improves hepatic fibrosis in MASH: Results of multimodality assessment using both conventional and digital pathology.
    Hepatology. 2024 Jun 25. doi: 10.1097/HEP.0000000000000980.
    

    >> Share

    
    
23. LUO X, Yu J
    Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury.
    Hepatology. 2024 Jun 25. doi: 10.1097/HEP.0000000000000984.
    

    >> Share

    
    
24. PREMKUMAR M, Kulkarni A, Izzy M
    'Regarding Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography'.
    Hepatology. 2024 Jun 26. doi: 10.1097/HEP.0000000000000988.
    

    >> Share

    
    
25. GAO D, Ping Yam JW
    Reversal of lipid metabolism as a therapeutic approach for hepatocellular carcinoma.
    Hepatology. 2024 Jun 27. doi: 10.1097/HEP.0000000000001000.
    

    >> Share

    
    

    
    Indian J Gastroenterol

26. DEVI J, Butt AS, Rai L, Kumar J, et al
    Gender disparities in gastroenterology and hepatology conferences: The journey towards equality.
    Indian J Gastroenterol. 2024 Jun 27. doi: 10.1007/s12664-024-01591.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

27. CHENG J, Yang S, Shou D, Chen J, et al
    FOXO1 induced fatty acid oxidation in hepatic cells by targeting ALDH1L2.
    J Gastroenterol Hepatol. 2024 Jun 25. doi: 10.1111/jgh.16662.
    

    >> Share

    
    
28. CHATZIPANAGIOTOU OP, Loukas C, Vailas M, Machairas N, et al
    Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature.
    J Gastroenterol Hepatol. 2024 Jun 23. doi: 10.1111/jgh.16663.
    

    >> Share

    
    

    
    J Hepatol

29. TARU V, Szabo G, Mehal W, Reiberger T, et al
    Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation.
    J Hepatol. 2024 Jun 20:S0168-8278(24)02322-5. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
30. FUSTER-ANGLADA C, Mauro E, Ferrer-Fabrega J, Caballol B, et al
    Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection.
    J Hepatol. 2024 Jun 24:S0168-8278(24)02324-9. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
31. ZHANG Y, Chen J, Su S
    The association between primary hypobetalipoproteinemia and hepatic Diseases: evidence from genetic studies.
    J Hepatol. 2024 Jun 24:S0168-8278(24)02328-6. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
32. ROONEY M, Duduskar SN, Ghait M, Reissing J, et al
    Type-I interferon shapes peritoneal immunity in cirrhosis and drives caspase-5-mediated progranulin release upon infection.
    J Hepatol. 2024 Jun 25:S0168-8278(24)02325-0. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    
33. THORHAUGE KH, Semmler G, Johansen S, Lindvig KP, et al
    Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
    J Hepatol. 2024;81:23-32.
    

    >> Share

    
    
34. HE S, Luo Y, Ma W, Wang X, et al
    Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis.
    J Hepatol. 2024;81:135-148.
    

    >> Share

    
    
35. CUSI K, Younossi Z, Roden M
    From NAFLD to MASLD: Promise and pitfalls of a new definition.
    J Hepatol. 2024;81:e18-e19.
    

    >> Share

    
    
36. RINELLA ME, Castro Narro GE, Krag A, Terrault N, et al
    Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition": EASL, AASLD and ALEH stand united to advance the field of steatotic liver disease.
    J Hepatol. 2024;81:e20-e21.
    

    >> Share

    
    

    
    N Engl J Med

37. GANAPATHI L, Cochran RL, Robbins GK, Barmettler S, et al
    Case 20-2024: A 73-Year-Old Man with Recurrent Fever and Liver Lesions.
    N Engl J Med. 2024;390:2309-2319.
    

    >> Share

    
    

    
    PLoS One

38. FARIA RM, Rosa SSRF, Nunes GAMA, Santos KS, et al
    Particle swarm optimization solution for roll-off control in radiofrequency ablation of liver tumors: Optimal search for PID controller tuning.
    PLoS One. 2024;19:e0300445.
    

    >> Share

    
    
39. LIU G, Zhang Q, Zhou M, Li B, et al
    Correlation between serum uric acid to high-density lipoprotein cholesterol ratio and atrial fibrillation in patients with NAFLD.
    PLoS One. 2024;19:e0305952.
    

    >> Share

    
    

    
    Transplantation

40. FRANCOZ C, Joly D, Legendre C
    Liver Transplantation for Polycystic Liver Disease: Definitely not a Cosmetic Surgery.
    Transplantation. 2024 May 21. doi: 10.1097/TP.0000000000005066.
    

    >> Share

    
    
41. MIYAKE K, Kim DY, Chau LC, Trudeau S, et al
    Exception Policy Change Increased the Simultaneous Kidney-liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
    Transplantation. 2024 Mar 29. doi: 10.1097/TP.0000000000004950.
    

    >> Share

    
    
42. TOSHIMA T, Harada N, Itoh S, Tomiyama T, et al
    What Are Risk Factors for Graft Loss in Patients Who Underwent Simultaneous Splenectomy During Living-donor Liver Transplantation?
    Transplantation. 2024 Feb 27. doi: 10.1097/TP.0000000000004952.
    

    >> Share

    
    
43. JAN MY, Patidar KR, Ghabril MS, Kubal CA, et al
    Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities.
    Transplantation. 2024 Jan 9. doi: 10.1097/TP.0000000000004851.
    

    >> Share

    
    
44. ZHOU K, Lit A, Kuo LS, Thompson LK, et al
    Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.
    Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004888.
    

    >> Share

    
    
45. KUSAKABE J, Kozato A, Tajima T, Bekki Y, et al
    Reappraisal of Donor Age in Liver Transplantation: NASH as a Potential Target to Safely Utilize Old Liver Grafts.
    Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004865.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share